Tocilizumab in giant cell arteritis. Observational, open-label multicenter study of 134 patients in clinical practice

Overview of attention for article published in Seminars in Arthritis & Rheumatism, January 2019

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (95th percentile)

So far, Altmetric has seen 4 news stories from 4 outlets.

Nei pazienti con arterite a cellule giganti refrattaria, tocilizumab si dimostrato efficace nel migliorare le manifestazioni…

medwireNews: Tocilizumab treatment results in a “rapid and maintained” clinical improvement among patients with giant cell…

Tocilizumab (Actemra) was effective for refractory giant cell arteritis (GCA) in real-world practice, although serious…

Tocilizumab (Actemra) was effective for refractory giant cell arteritis (GCA) in real-world practice, although serious…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.